SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
מצבים רפואיים
Ovarian Cancer Recurrent
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
St James's University Hospital, Leeds, Leeds, United Kingdom
Contact: Study coordinator (Amy Burkinshaw) · leedsth-tr.oncologydatamanagement@nhs.net · 01132068603Contact: Principal Investigator (Geoff Hall, Professor)Leicester Royal Infirmary, Leicester, Leicester, United Kingdom
Contact: Principal Investigator (Anu Gore)The Christie NHS Foundation Trust, Manchester, Manchester, United Kingdom
Contact: Principal Investigator (Lisa Barraclough)Gordon Jayson (Sub-investigator)Western General Hospital, Edinburgh, Scotland, United Kingdom
Contact: Principal Investigator (Charlie Gourley)Iain Phillips (Sub-investigator)The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Contact: Principal Investigator (Susana Banerjee)Alexandra Taylor (Sub-investigator)University College London Hospitals, London, UK, United Kingdom
Contact: Principal Investigator (Gemma Eminowicz)Rowan Miller (Sub-investigator)The Royal Marsden NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Susana Banerjee)Alexandra Taylor (Sub-investigator)
מובילי המחקר
Susana Banerjee
Principal Investigator
Royal Marsden NHS Foundation Trust